Observational studyClinical cardiology2022

Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD).

Aleesha Shaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.